Syrian Arab Republic vs Trinidad and Tobago: Previously treated cases tested for RR-/MDR-TB

Syrian Arab Republic
32.0%
in 2024
Trinidad and Tobago
27.0%
in 2024
Syrian Arab Republic rank
160th
Trinidad and Tobago rank
163rd

Previously treated cases tested for RR-/MDR-TB over time

  • Syrian Arab Republic
  • Trinidad and Tobago
020406080100200520142024

How they compare

Syrian Arab Republic currently reports 32.0% against 27.0% in Trinidad and Tobago, a difference of 5.0%.

That makes Syrian Arab Republic's figure about 1.2 times Trinidad and Tobago's.

The two have swapped places 3 times across 18 shared years of data; in 2005 it was Trinidad and Tobago ahead.

Syrian Arab Republic ranks 160th and Trinidad and Tobago ranks 163rd of 180 countries.

Across the 3 decades both report, Syrian Arab Republic averaged higher in 2 and Trinidad and Tobago in 1.

Head to head by decade

Decade Syrian Arab Republic Trinidad and Tobago Difference Ahead
2000s 7.0% 23.3% 16.3% Trinidad and Tobago
2010s 54.5% 44.8% 9.8% Syrian Arab Republic
2020s 86.4% 32.0% 54.4% Syrian Arab Republic

Averages of every year both report within each decade.

Frequently asked questions

Which has higher previously treated cases tested for rr-/mdr-tb, Syrian Arab Republic or Trinidad and Tobago?
Syrian Arab Republic, at 32.0% against 27.0% in Trinidad and Tobago as of 2024.
What is the difference in previously treated cases tested for rr-/mdr-tb between Syrian Arab Republic and Trinidad and Tobago?
5.0%, with Syrian Arab Republic ahead.
How many years of comparable data are there for Syrian Arab Republic and Trinidad and Tobago?
18 years are reported by both, from 2005 to 2024.
How do Syrian Arab Republic and Trinidad and Tobago rank globally for previously treated cases tested for rr-/mdr-tb?
Syrian Arab Republic ranks 160th and Trinidad and Tobago ranks 163rd of 180 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Syrian Arab Republic vs Trinidad and Tobago: Previously treated cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 14 September 2026, from https://health.statizoid.com/compare/previously-treated-cases-tested-for-rr-mdr-tb-percent/syrian-arab-republic/trinidad-and-tobago/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/previously-treated-cases-tested-for-rr-mdr-tb-percent/syrian-arab-republic/trinidad-and-tobago/">Syrian Arab Republic vs Trinidad and Tobago: Previously treated cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
193 places, 3,089 data points, 2005–2024
Last refreshed